Year archive

NFL Biosciences — 2021 filings

All 11 regulatory filings released by NFL Biosciences (ALNFL) in 2021, sourced directly from the official regulator.

11 Filings

2021 Period

2021 filings (11)

Filing	Released	Lang
NFL Biosciences: Phase II/III clinical trial launched for smoking cessation Regulatory Filings	2021-12-14	English
NFL Biosciences : lancement de l’étude clinique de Phase II/III pour le sevrage tabagique Regulatory Filings	2021-12-14	French
NFL BIOSCIENCES: agreement signed with Diverchim to manufacture its active ingredients Regulatory Filings	2021-11-17	English
NFL BIOSCIENCES : accord de production de ses principes actifs avec Diverchim Regulatory Filings	2021-11-17	French
NFL Biosciences : Rapport Financier Semestriel au 30 juin 2021 Interim / Quarterly Report H1 2021	2021-10-04	French
NFL BIOSCIENCES : Activités et résultats du 1er semestre 2021 Interim / Quarterly Report H1 2021	2021-10-04	French
NFL BIOSCIENCES: 2021 half-year financial and business report Earnings Release H2 2021	2021-10-04	English
NFL BIOSCIENCES : Accord de délivrance de son brevet aux États-Unis Investor Presentation	2021-09-21	French
NFL BIOSCIENCES: approval for its patent to be granted in the United States Regulatory Filings	2021-09-21	English
NFL Biosciences : l’étude clinique de Phase II/III de NFL-101 pour le sevrage tabagique approuvée en France Regulatory Filings	2021-09-15	French
NFL BIOSCIENCES: Phase II/III clinical trial for NFL-101 for smoking cessation approved in Franc Regulatory Filings	2021-09-15	English